Skip to main content
Clinical Trials/NCT04531384
NCT04531384
Recruiting
Not Applicable

Randomized Clinical Trial of Robot-Assisted Intelligent Rehabilitation Treatment in Comparison With Standard Treatment for Methamphetamine Use Disorders and Alcohol Use Disorders

Shanghai Mental Health Center1 site in 1 country200 target enrollmentDecember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Amphetamine Addiction
Sponsor
Shanghai Mental Health Center
Enrollment
200
Locations
1
Primary Endpoint
Changes of galvanic skin response during the virtual reality based addiction assessment system
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this research is to evaluate the efficacy and safety of Robot-assisted rehabilitation intelligent system as a virtual stand-alone treatment, delivered with minimal clinical monitoring compared with treatment as usual in methamphetamine (MA) use disorders.

Detailed Description

Based on artificial intelligence technology, face recognition technology, virtual reality technology to develop an available Robot-assisted rehabilitation intelligent system. Then, using this intelligent system as a new way of Psychotherapy to provide treatment for methamphetamine patients, and compare it with traditional treatment to verify the efficacy and safety of Robot-assisted rehabilitation intelligent system in Chinese methamphetamine patients.

Registry
clinicaltrials.gov
Start Date
December 1, 2020
End Date
December 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders;
  • Education level equal or more than 9 years;
  • Have normal or corrected-to-normal vision;
  • Have normal or corrected-to-normal hearing;
  • Less than 3 months before last drug use;

Exclusion Criteria

  • Current substance use (except nicotine or caffeine);
  • History of disease which influence cognition,such as seizure disorder、cerebrovascular disease、head injury or other severe medication conditions;
  • Intelligence quotient less than 70.

Outcomes

Primary Outcomes

Changes of galvanic skin response during the virtual reality based addiction assessment system

Time Frame: in 1 year

The galvanic skin response is an emotional physiological indicator, and its unit is ohm.

Secondary Outcomes

  • Treatment motivation(in 1 year)
  • Reaction inhibition ability(in 1 year)
  • Anxiety(in 1 year)
  • Depression(in 1 year)
  • Attentional bias related to drugs and emotional stimulation(in 1 year)
  • Risky decision-making(in 1 year)
  • Changes of electroencephalogram power spectrum during the virtual reality based addiction(in 1 year)

Study Sites (1)

Loading locations...

Similar Trials